Neuro-Oncology Reviews

Volume 25 Number 8
30 April 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 8, 30 April

Hassan SN, Yusoff AAM, Idris Z, Redzwan NM, Ahmad F.
A mini-review on anticancer-related properties of azithromycin and its potential activities in overcoming the challenges of glioblastoma.
Fundam Clin Pharmacol. 2023 Apr 17∟. doi: 10.1111/fcp.12900∟. PMID: 37069134∟. Review˰ ˍ

Park YW, Vollmuth P, Foltyn-Dumitru M, Sahm F, Ahn SS, Chang JH, Kim SH.
The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas.
J Magn Reson Imaging. 2023 Apr 17∟. doi: 10.1002/jmri.28743∟. PMID: 37069792∟. Review. ˍ

Park YW, Vollmuth P, Foltyn-Dumitru M, Sahm F, Ahn SS, Chang JH, Kim SH.
The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas.
J Magn Reson Imaging. 2023 Apr 17∟. doi: 10.1002/jmri.28740∟. PMID: 37069764∟. Review. ˍ

Singh H.
Role of Molecular Targeted Therapeutic Drugs in Treatment of Glioblastoma: A Review Article.
Glob Med Genet. 2023 Apr 17;10(2):42-47∟. doi: 10.1055/s-0043-57028∟. PMID: 37077370∟. Review. ˍ

*

Badaloni ME, Johnson AR, Argañaraz R, Mantese B.
Intratumoral catheter placement in pediatric patients with diffuse midline gliomas.
Childs Nerv Syst. 2023 Apr 18∟. doi: 10.1007/s00381-023-05950-z∟. PMID: 37072561∟. Review˰ ˍ

Fabbri R, Cacopardo L, Ahluwalia A, Magliaro C.
Advanced 3D Models of Human Brain Tissue Using Neural Cell Lines: State-of-the-Art and Future Prospects.
Cells. 2023 Apr 18;12(8):1181∟. doi: 10.3390/cells12081181∟. PMID: 37190089∟. Review. ˍ

Hauff NS, Storstein A.
Seizure Management and Prophylaxis Considerations in Patients with Brain Tumors.
Curr Oncol Rep. 2023 Apr 18∟. doi: 10.1007/s11912-023-01410-8∟. PMID: 37071297∟. Review. ˍ

*

Nishioka K, Takahashi S, Mori T, Uchinami Y, Yamaguchi S, Kinoshita M, Yamashina M, Higaki H, Maebayashi K, Aoyama H.
The need of radiotherapy optimization for glioblastomas considering immune responses.
Jpn J Radiol. 2023 Apr 18∟. doi: 10.1007/s11604-023-01434-x∟. PMID: 37071249∟. Review. ˍ

Pellerino A, Bruno F, Soffietti R, Rudà R.
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
Curr Oncol Rep. 2023 Apr 18∟. doi: 10.1007/s11912-023-01417-1∟. PMID: 37071295∟. Review. ˍ

Wang C, Li Y, Gu L, Chen R, Zhu H, Zhang X, Zhang Y, Feng S, Qiu S, Jian Z, Xiong X.
Gene Targets of CAR-T Cell Therapy for Glioblastoma.
Cancers (Basel). 2023 Apr 18;15(8):2351∟. doi: 10.3390/cancers15082351∟. PMID: 37190280∟. Review. ˍ

Sakly H, Said M, Seekins J, Guetari R, Kraiem N, Marzougui M.
Brain Tumor Radiogenomic Classification of O⁶-Methylguanine-DNA Methyltransferase Promoter Methylation in Malignant Gliomas-Based Transfer Learning.
Cancer Control. 2023 Apr 19;30:10732748231169149∟. doi: 10.1177/10732748231169149∟. PMID: 37078100∟. Review. ˍ

Luo T, Feng J, Sun P.
Fractionated stereotactic re-irradiation for recurrent glioblastoma: A systematic review and meta-analysis.
Clin Neurol Neurosurg. 2023 Apr 20;229:107728∟. doi: 10.1016/j.clineuro.2023.107728∟. PMID: 37105068∟. Review, Meta-analysis˰ ˍ

*

van der Meer PB, Dirven L, Hertler C, Boele FW, Batalla A, Walbert T, Rooney AG, Koekkoek JAF.
Depression and anxiety in glioma patients.
Neurooncol Pract. 2023 Apr 20;10(4):335-343∟. doi: 10.1093/nop/npad019∟. PMID: 37457222∟. Review. ˍ

Zhou X, Jin G, Zhang J, Liu F.
Recruitment mechanisms and therapeutic implications of tumor-associated macrophages in the glioma microenvironment.
Front Immunol. 2023 Apr 20;14:1067641∟. doi: 10.3389/fimmu.2023.1067641∟. PMID: 37153567∟. Review. ˍ

Howley R, Chandratre S, Chen B.
5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy.
Bioengineering (Basel). 2023 Apr 21;10(4):496∟. doi: 10.3390/bioengineering10040496∟. PMID: 37106683∟. Review. ˍ

Sperring CP, Argenziano MG, Savage WM, Teasley DE, Upadhyayula PS, Winans NJ, Canoll P, Bruce JN.
Convection-enhanced delivery of immunomodulatory therapy for high-grade glioma.
Neurooncol Adv. 2023 Apr 21;5(1):vdad044∟. doi: 10.1093/noajnl/vdad044∟. PMID: 37215957∟. Review. ˍ

Thang M, Mellows C, Mercer-Smith A, Nguyen P, Hingtgen S.
Current approaches in enhancing TRAIL therapies in glioblastoma.
Neurooncol Adv. 2023 Apr 21;5(1):vdad047∟. doi: 10.1093/noajnl/vdad047∟. PMID: 37215952∟. Review. ˍ

Lyu Y, Guo Y, Okeoma CM, Yan Z, Hu N, Li Z, Zhou S, Zhao X, Li J, Wang X.
Engineered extracellular vesicles (EVs): Promising diagnostic/therapeutic tools for pediatric high-grade glioma.
Biomed Pharmacother. 2023 Apr 22;163:114630∟. doi: 10.1016/j.biopha.2023.114630∟. PMID: 37094548∟. Review. ˍ

Guo X, Wang G.
Advances in research on immune escape mechanism of glioma.
CNS Neurosci Ther. 2023 Apr 23∟. doi: 10.1111/cns.14217∟. PMID: 37088950∟. Review. ˍ

Montemurro N, Pahwa B, Tayal A, Shukla A, De Jesus Encarnacion M, Ramirez I, Nurmukhametov R, Chavda V, De Carlo A.
Macrophages in Recurrent Glioblastoma as a Prognostic Factor in the Synergistic System of the Tumor Microenvironment.
Neurol Int. 2023 Apr 23;15(2):595-608∟. doi: 10.3390/neurolint15020037∟. PMID: 37218976∟. Review. ˍ

Rocha Pinheiro SL, Lemos FFB, Marques HS, Silva Luz M, de Oliveira Silva LG, Faria Souza Mendes Dos Santos C, da Costa Evangelista K, Calmon MS, Sande Loureiro M, Freire de Melo F.
Immunotherapy in glioblastoma treatment: Current state and future prospects.
World J Clin Oncol. 2023 Apr 24;14(4):138-159∟. doi: 10.5306/wjco.v14.i4.138∟. PMID: 37124134∟. Review. ˍ

Servidei T, Sgambato A, Lucchetti D, Navarra P, Ruggiero A.
Drug Repurposing in Pediatric Brain Tumors: Posterior Fossa Ependymoma and Diffuse Midline Glioma under the Looking Glass.
Front Biosci (Landmark Ed). 2023 Apr 24;28(4):77∟. doi: 10.31083/j.fbl2804077∟. PMID: 37114548∟. Review. ˍ

Bispo RG, Bastos Siqueira IF, de Oliveira BFS, Moreira Fernandes CE, Figueiredo LA, Cintra LP, de Oliveira AJM.
Prognostic value of the platelet-lymphocyte ratio for Glioblastoma: A systematic review.
World Neurosurg. 2023 Apr 25:S1878-8750(23)00571-5∟. doi: 10.1016/j.wneu.2023.04.086∟. PMID: 37105273∟. Review˰ ˍ

Martins C, Sarmento B.
Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine.
Wiley Interdiscip Rev Nanomed Nanobiotechnol∟. 2023 Apr 25:e1893. doi: 10.1002/wnan.1893∟. PMID: 37186374∟. Review. ˍ

Hervás-Corpión I, Alonso MM.
Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success.
Int Rev Cell Mol Biol. 2023 Apr 26;379:169-188∟. doi: 10.1016/bs.ircmb.2023.04.001∟. PMID: 37541723∟. Review, Book chapter˰ ˍ

Kim HJ, Suh CO.
Radiotherapy for Diffuse Intrinsic Pontine Glioma: Insufficient but Indispensable.
Brain Tumor Res Treat. 2023 Apr 27;11(2):79-85∟. doi: 10.14791/btrt.2022.0041∟. PMID: 37151149∟. Review. ˍ

Kim MS, Go SI, Wee CW, Lee MH, Kang SG, Go KO, Kwon SM, Kim W, Dho YS, Park SH, Seo Y, Song SW, Ahn S, Oh HJ, Yoon HI, Lee SW, Lee JH, Cho KR, Choi JW, Hong JB, Hwang K, Park CK, Lim DH; KSNO Guideline Working Group.
The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Recommendation Using the Delphi Method (Version 2023.1).
Brain Tumor Res Treat. 2023 Apr 27;11(2):123-132∟. doi: 10.14791/btrt.2023.0009∟. PMID: 37151154∟. Guidelines. ˍ

Park J, Chung C.
Epigenetic and Metabolic Changes in Diffuse Intrinsic Pontine Glioma.
Brain Tumor Res Treat. 2023 Apr 27;11(2):86-93∟. doi: 10.14791/btrt.2023.0011∟. PMID: 37151150∟. Review. ˍ

Sokolov E, Dietrich J, Cole AJ.
The complexities underlying epilepsy in people with glioblastoma.
Lancet Neurol. 2023 Apr 27:S1474-4422(23)00031-5∟. doi: 10.1016/S1474-4422(23)00031-5∟. PMID: 37121239∟. Review˰ ˍ

Lee J, Lukas RV, Jusue-Torres I, Germanwala AV, Borys E, Solanki AA, Mallik AK, Barton K, Thakkar JP.
MGMT Methylated High Grade Glioma with Distant Recurrence and Stable Original Tumor Site: Case Series.
Ann Hematol Oncol. 2023 Apr 29;10(2):1421∟. doi: 10.26420/annhematoloncol.2023.1421∟. PMID: 37309512∟. Case report, Review. ˍ